Axiogenesis Inks Sublicensing Agreement with GE Healthcare for Stem Cell IP – GenomeWeb
|
Axiogenesis Inks Sublicensing Agreement with GE Healthcare for Stem Cell IP
GenomeWeb NEW YORK (GenomeWeb) –Axiogenesis today announced it has sublicensed patents from GE Healthcare to allow the German cell supplier to commercialize technologies based on human induced pluripotent stem cells (iPSCs). Under the terms of the … Axiogenesis Signs Sublicensing Agreement for Cellular Assay Patents with GE … |
